The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Nov. 26, 2009
Applicants:

Warren H. Finlay, Edmonton, CA;

Jonathan J. Dennis, Edmonton, CA;

Helena Orszanska, Edmonton, CA;

Kimberley D. Seed, Boston, MA (US);

Karlene Heather Lynch, Edmonton, CA;

Inventors:

Warren H. Finlay, Edmonton, CA;

Jonathan J. Dennis, Edmonton, CA;

Helena Orszanska, Edmonton, CA;

Kimberley D. Seed, Boston, MA (US);

Karlene Heather Lynch, Edmonton, CA;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/76 (2006.01); A61K 9/00 (2006.01); A61K 47/26 (2006.01);
U.S. Cl.
CPC ...
A61K 35/76 (2013.01); A61K 9/0075 (2013.01); C12N 2795/00032 (2013.01); Y10S 977/704 (2013.01); Y10S 977/773 (2013.01); Y10S 977/795 (2013.01); Y10S 977/904 (2013.01);
Abstract

A respirable composition for treatment of a bacterial infection includes one or more active bacteriophages in combination with a pharmaceutically acceptable respirable carrier. The composition includes a carbohydrate carrier, and is prepared as fine powder. In another aspect, bacteriophages are provided in a liquid carrier for administration by nebulization. In one aspect, the bacteriophages have anti-bacterial activity against one or more species or strains ofcomplex (BCC) bacteria. The invention further relates to the use of a BCC bacteriophage to treat a BCC infection, in particular in an individual suffering from cystic fibrosis.


Find Patent Forward Citations

Loading…